Onconova Therapeutics,Inc. (NASDAQ:ONTX) Files An 8-K Results of Operations and Financial ConditionItem 2.02. Results of Operations and Financial Condition
On November9, 2017, Onconova Therapeutics,Inc. (the “Company”) issued a press release announcing its financial results for the quarter and nine months ended September30, 2017, a copy of which is attached hereto as Exhibit99.1 and incorporated herein by reference. The information contained in this Form8-K (including the exhibit hereto) shall not be deemed “filed” for purposes of Section18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.
Item 2.02. Financial Statements and Exhibits
(d)Exhibits.
99.1 Press release issued by the Company dated November9, 2017.